Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is expected to announce its results before the market opens on Thursday, August 20th. Analysts expect Novozymes A/S to announce earnings of $0.6170 per share and revenue of $1.2632 billion for the quarter.
Novozymes A/S Trading Down 3.3%
Novozymes A/S stock opened at $64.37 on Wednesday. Novozymes A/S has a 52 week low of $52.10 and a 52 week high of $67.50. The firm’s 50-day simple moving average is $62.72 and its 200 day simple moving average is $60.02.
Novozymes A/S Company Profile
Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.
Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing.
Recommended Stories
- Five stocks we like better than Novozymes A/S
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
